Allstate Corporation (The) (ALL) Stock Price & How to Invest

Allstate collects premiums from roughly 216 million policies in force and pays claims on them, keeping the difference plus whatever its large investment portfolio earns. Auto insurance is the biggest single line, followed by homeowners, with additional revenue from protection plans, roadside services and identity protection sold under the Allstate Protection Plans banner. Distribution runs through exclusive and independent agents, direct online and phone channels, and the National General and Direct Auto brands that reach non-standard and lower-premium drivers. Over 2022 and 2023 the auto book was badly underwater as used-car values, parts costs and repair labor all inflated faster than approved rates, which is why fiscal 2023 closed at a net loss of roughly $316 million on about $57.1 billion of revenue.

What followed was a textbook hard-market recovery. Rate increases filed during the loss years earned into the book while claim severity cooled, and margins snapped back hard: fiscal 2025 revenue reached about $67.7 billion with roughly $10.2 billion of net income, and the trailing twelve months through June 2026 sit near $70.1 billion of revenue and roughly $13.2 billion of net income. Second quarter 2026 revenue of about $18.6 billion was up roughly 11.8 percent year over year, net income was about $3.2 billion, and the property-liability combined ratio improved 4.5 points to 86.6 with an underlying combined ratio near 79.4. Those are exceptional numbers for personal lines, helped in the quarter by roughly $1.5 billion of favorable auto reserve development, and they are the reason the reported earnings multiple looks far lower than the forward one.

Catastrophe exposure is the structural risk: a single severe hurricane, wildfire or convective-storm season can move a quarter by billions, and homeowners growth increases that exposure. Margins this wide historically compress as competitors cut price to win share, so the current combined ratio should be treated as a cyclical peak rather than a run rate. Reserve development cuts both ways, and the roughly $1.5 billion favorable auto release in the second quarter of 2026 is not a repeatable earnings source. Regulatory risk is real and specific: state insurance departments approve rates, and several large states have been slow or restrictive on homeowners filings. Allstate also faces active consumer privacy litigation over driving-data collection through its Arity subsidiary, including a Texas Attorney General action and federal wiretap and Fair Credit Reporting Act claims that a court allowed to proceed, plus plaintiffs'-firm activity following reports of a 2026 data incident. The prior securities class action, In re The Allstate Corporation Securities Litigation, No. 16-cv-10510 in the Northern District of Illinois, was settled for $90 million with final approval in December 2023 and is closed.

22 analysts publish price targets on ALL, averaging $267.77 against a $267.00 price as of August 2026, or +0.3%. The published targets run from $176.00 to $334.00, a moderate spread, and the ratings split 11 buy, 11 hold, 3 sell. Over the last six months there have been 11 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ALL forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Allstate Corporation (The). Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Underwriting margin at the top of the cycle. An 86.6 combined ratio means Allstate paid out about 86.6 cents of claims and expense per premium dollar, keeping the rest as underwriting profit before investment income. The most optimistic published target, $334.00, assumes this works close to its best case.

The case against. Catastrophe exposure is the structural risk: a single severe hurricane, wildfire or convective-storm season can move a quarter by billions, and homeowners growth increases that exposure. The most pessimistic target, $176.00, is roughly what ALL is worth if this bites instead.

Read the full bull and bear case on ALL, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Allstate Corporation (The)'s investor relations page or your broker.

• Market cap: ~$67.5B
• Revenue (TTM): ~$70.1B
• Net income (TTM): ~$13.2B
• Trailing P/E: ~5.3x
• Forward P/E: ~9.7x
• Dividend yield: ~1.6% (~$4.32 annualized)

The trailing multiple near 5.3x is misleading on its own. Trailing net income of roughly $13.2 billion includes one-time gains from the 2025 divestitures of the benefits and group health businesses plus an unusually favorable underwriting year, so the forward multiple near 9.7x is the more representative figure and implies the market expects earnings to normalize well below the trailing level. Second quarter 2026 adjusted net income, which strips out investment gains and non-recurring items, was about $2.3 billion or $8.99 per diluted share against roughly $1.6 billion a year earlier.

If you want ALL exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

Other names that sit close to ALL: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get ALL exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (RDVY, IWS, FMDE), which spreads the position across many companies. Or build it into a focused thematic portfolio, so ALL sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ALL fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Allstate is a scale personal-lines insurer earning through the good half of an underwriting cycle, so the question that matters is how much of today's margin survives when pricing normalizes.

Whether ALL is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ALL a buy or a sell?, and where the stock could go from here in the ALL stock forecast.

For income investors, whether ALL pays a dividend and how the payout looks is covered in does ALL pay a dividend? And to weigh ALL against a peer, read the full side-by-side comparisons: ALL vs PGR and ALL vs BRK-B.